Listed

Adagio Medical Holdings, Inc.: Form 10-Q for the period ended Jun 30, 2024

Filed with the SEC on Aug 26, 2024 and accepted by EDGAR at Aug 26, 2024, 17:00 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2024-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Net income3 months2024-04-01 to 2024-06-30−$713.8kus-gaap:NetIncomeLoss
Net income6 months2024-01-01 to 2024-06-30−$2.1mus-gaap:NetIncomeLoss
Diluted EPS3 months2024-04-01 to 2024-06-30−$713794.00us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2024-01-01 to 2024-06-30−$2134199.00us-gaap:EarningsPerShareDiluted
Basic EPS3 months2024-04-01 to 2024-06-30−$713794.00us-gaap:EarningsPerShareBasic
Basic EPS6 months2024-01-01 to 2024-06-30−$2134199.00us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2024-04-01 to 2024-06-301 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2024-01-01 to 2024-06-301 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2024-01-01 to 2024-06-30$0us-gaap:NetCashProvidedByUsedInOperatingActivities
Total liabilitiesAt period end2024-06-30$5.0kus-gaap:Liabilities
Shareholders' equityAt period end2024-06-30−$5.0kus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001410578-24-001560. Last ingested by Listed: Nov 11, 2026, 03:39 ET. Listed shows no prices and gives no investment advice.